TNFRSF4 and atopic conjunctivitis: In a murine model of experimental allergic conjunctivitis, in vivo stimulation of OX40 with an anti-OX40 antibody led to the exacerbation of ocular surface inflammatory disease, while antibody blockade of the OX40/OX40L interaction inhibited disease expression [20].